Good 5-year outcomes after argon plasma coagulation for Barrett's esophagus
This article has no abstract so we have provided the first paragraph of the full text.
Various ablative techniques, such as argon plasma coagulation (APC), have been shown to reduce the extent of Barrett's esophagus, a major risk factor for esophageal adenocarcinoma. Long-term outcomes and the effects of APC on esophageal cancer risk, however, have not been demonstrated. Bright and colleagues have reported the 5-year outcomes from a randomized trial of APC versus endoscopic surveillance in patients with Barrett's esophagus.
Full text of this article is available with one of the following:
- Membership of the American College of Gastroenterology. If already a member, please login.
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
